1. Extrahepatic tissue distribution, covalent binding, and toxicity of halothane in control and phenobarbital-pretreated rats;Rao;Pharmacology and Therapeutics in Dentistry,1978
2. Time-course of formation of volatile reductive metabolites of halothane in humans and an animal model;Gourlay;British Journal of Anaesthesiology,1980
3. Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis;Christ;Anesthesiology,1988
4. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane;Kharasch;Anesthesiology,1993
5. Characteristics and implications of desflurane metabolism and toxicity;Koblin;Anesthesia & Analgesia,1992